FreeCME

The 12th Annual Linda Morgante MS Nurse Leadership Program

/ Print /
| ShareMore
/ Text Size +
6/26/21 10:00 am EDT
Virtual Webinar

Supported by educational grants from Bristol-Myers Squibb, EMD Serono, Inc., Greenwich Biosciences, Inc., Novartis Pharmaceuticals Corporation and Sanofi Genzyme.

Webinar Overview:

The 12th Annual Linda Morgante MS Nurse Leadership Program will be held virtually on Saturday, June 26, 2021. This virtual meeting will help multiple sclerosis (MS) nurses refine their ability to translate evidence-based guidelines and emerging clinical research into practice. Linda Morgante worked tirelessly as an MS nurse and touched the lives of thousands of physicians, nurses and patients and their families. Linda inspired her students to strive for excellence in nursing and this program aims to carry on her legacy. This program will feature didactic presentations, patient case mentoring pods, office hours for faculty to reinforce key points, engage in Q&A, and discuss current challenges and frame opportunities in professional development.

The program will provide 5.0 American Nurses Credentialing Center (ANCC) contact hours for nurses.

Upon completion of this activity, learners should be better able to:

  • Apply evidence-based diagnostic and assessment approaches for evaluating disease activity in the brain and spinal cord to develop individualized treatment plans in patients with MS
  • Improve patient outcomes and adherence to therapy by identifying, assessing, and managing emerging MS-related symptoms and DMT-related adverse events.
  • Employ treat-to-target strategies and precision medicine to improve patient long-term outcomes 

Target Audience

This activity is intended for nurses and advanced practice clinicians who manage patients with multiple sclerosis (MS).

Date and Time:

This webinar will be held on:

  • Saturday, June 26, 2021 10:00AM - 4PM EST

Chairs:
Colleen Harris, MN, NP, MSCN, MSCS
Nurse Practitioner      
University of Calgary MS Clinic
Calgary, Alberta, Canada


Amy Perrin Ross, APN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Chicago Medical Center
Maywood, Illinois

Faculty:
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN, MSCN
Adjunct Assistant Professor
Co-Director Research/EBP/QI
Mount Sinai Medical Center
Assistant Professor
Researcher, Hunter College 
Bellevue School of Nursing 
New York, New York


Cheryl Blaschuk, MSN
Nurse Practitioner
Medical College of Wisconsin
Comprehensive Multiple Sclerosis Clinic
Froedtert & Medical College of Wisconsin 
Wauwatosa, Wisconsin

 

Constance Easterling, MSN, ARNP, MSCN
Advanced Practice Registered Nurse
Research consultant
MS Care Center
Neurological Services of Orlando
Orlando, Florida

 

June Halper, MSN, APN-C, MSCN, FAAN
Chief Executive Officer
Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses
Hackensack, New Jersey

 

Michelle Keating, RN, MSCN
MS Nurse Consultant
St. Louis, Missouri 

 

Beverly Layton, RN, CCRC, MSCN
MS Nurse Consultant
Birmingham, Alabama

 

Lynn McEwan, NP, MScN, CNN(c), MSCN
London Health Sciences Centre-University Hospital
London, Ontario Canada

 

Marie Namey APRN, MSCN
MS Nurse Consultant
Recently retired from Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research
Cleveland, Ohio


Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.  


Credit Designation

A maximum of 5.0 contact hours, which includes pharmacology hours*, may be earned for successful completion of this activity. 

*Pharmacology hours TBD


Disclosure of Conflicts of Interest

Annenberg Center and ACHL requires that the faculty participating in a CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CE activity.

The following financial relationships have been provided:

Colleen Harris, MN, NP (Chair)
Consulting Agreements: Biogen; EMD Serono; Genzyme; Roche
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

 

Amy Perrin Ross, APN, MSN, CNRN, MSCN
Consulting Agreements: Celgene; EMD Serono; Genentech; Genzyme; Mallinckrodt; Roche; Teva
Speakers' Bureau: Acorda; Biogen; EMD Serono; Genentech; Genzyme; Mallinckrodt; Novartis; Teva
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

 

Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN, MSCN
Publication grant: EMD Serono; Greenwich Biosciences
Consulting Agreements: Biogen
Advisory Board: Biogen; Genentech; Greenwich Biosciences 
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: My discussion may include off label treatments for the care of MS.

 

Beverly Layton, RN, CCRC, MSCN
Consulting Agreements: Banner Life Sciences; Biogen; Novartis; Sanofi Genzyme
Speakers' Bureau: Sanofi Genzyme
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

 

Lynn McEwan, NP, MScN, CNN(c), MSCN
Consulting Agreements: BMS; EMD Serono; Novartis; Roche; Sanofi Genzyme 
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

 

Marie Namey APRN, MSCN
Consulting Agreements: Biogen; EMD Serono; Genentech; Novartis; Sanofi; Viela Bio
Speakers' Bureau: Biogen; Genentech; Novartis; Sanofi 
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

 

The following faculty have no relevant financial relationships to disclose, and will not be discussing off-label, investigational, or experimental drug use:
Cheryl Blaschuk, MSN
Constance Easterling, MSN, ARNP, MSCN
June Halper, MSN, APN-C, MSCN, FAAN
Michelle Keating, RN, MSCN


Instructions for Participation and Credit

To receive credit, participants are required to complete the pretest, participate in the live virtual activity and complete the posttest and evaluation. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact Katie Hacias at khacias@achlcme.org


Course Viewing Requirements

  1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
  2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
  3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
  4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
  5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
  6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.

Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker


Disclaimer

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ANCC Accreditation Program. Recommendations involving clinical medicine in a continuing medical education (CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. Annenberg and ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Contact Information

For CME questions please contact: Katie Hacias at khacias@achlcme.org